Entries by Rob Coleman

Test — Agilum Releases Nationwide COVID-19 Real-World Data (RWD) Survival Rate Analytics

Updated daily by 12:30 PM ET By: William D. Kirsh, DO, MPH, CMIO, Agilum Healthcare Intelligence, Inc. and Travis J. Leonardi, RPh, C.P., CEO of Agilum Healthcare Intelligence, Inc. Through its Comparative Rapid Cycle Analytics™ (CRCA™) solution, Agilum Healthcare Intelligence seeks to leverage its comprehensive, longitudinal patient database to deliver updates on current and new […]

Agilum Releases Additional RWD Survival Rate Analytics for HCQ or CQ and Acetazolamide

Updated June 30, 2020 Agilum first began publishing RWD on COVID-19 hospital admissions on April 7, 2020. The real-world data (RWD) were refreshed daily and showed notable differences in survival rates and ALOS across recognized drug treatment regimens. This analysis was presumptive in nature and sought to produce RWD in near-real-time to advance the care […]

Agilum Releases New York State COVID-19 Drug Utilization Trends Using Real-World Data (RWD) to Help Hospitals Predict Shifting Drug Demand

Updated June 30, 2020   By: Dawn DeAngelo, BS, PharmD, Chief Pharmacy Officer, Agilum Healthcare Intelligence, Inc. and Travis J. Leonardi, RPh, C.P., CEO of Agilum Healthcare Intelligence, Inc.   In response to the rapidly evolving COVID-19 pandemic, Agilum Healthcare Intelligence analyzed real-world data (RWD) from over 29% of the hospital beds in New York […]